SCTB14

DRUG2 trials

Sponsors

Sinocelltech Ltd.

Conditions

Advanced Malignant Solid TumoursNon-Small Cell Lung Carcinoma (NSCLC)

Phase 1

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.

Not yet recruitingNCT06304818

Sinocelltech Ltd.Advanced Malignant Solid Tumours

Start: 2024-04-30End: 2028-12-30Target: 515Updated: 2024-03-15

Phase 3

A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer.

RecruitingNCT07362459

Sinocelltech Ltd.Non-Small Cell Lung Carcinoma (NSCLC)

Start: 2025-12-30End: 2029-09-01Target: 246Updated: 2026-01-23